Suzhou Ribo Life Science Co., Ltd. (HKG:6938)
Hong Kong · Delayed Price · Currency is HKD 51.05
+1.05 (2.10%)
Jul 3, 2026, 4:08 PM HKT
Suzhou Ribo Life Science Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Suzhou Ribo Life Science stock has a consensus rating of "Strong Buy" and an average price target of $102.57. The average 1-year stock price forecast is 100.92% higher than the current stock price, while the lowest is $97.10 (+90.21%) and the highest is $109.69 (+114.87%).
Price Target: $102.57 (+100.92%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Suzhou Ribo Life Science stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $119.06 | Buy | Maintains | $119.06 | +133.22% | Jun 5, 2026 |
Unknown Analyst Soochow Securities No rating | Soochow Securities | Buy Maintains $115.80 | Buy | Maintains | $115.80 | +126.84% | May 20, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $100.00 → $90.00 | Buy | Maintains | $100.00 → $90.00 | +76.30% | Apr 4, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains $102.00 | Buy | Maintains | $102.00 | +99.80% | Mar 30, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $86.08 | Buy | Maintains | $86.08 | +68.62% | Mar 6, 2026 |
Financial Forecast
Revenue This Year
255.33M
from 148.51M
Increased by 71.93%
Revenue Next Year
151.25M
from 255.33M
Decreased by -40.76%
EPS This Year
-7.94
from -1.97
EPS Next Year
-140.16
from -7.94
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 442.0M | ||
| Avg | 255.3M | ||
| Low | 134.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 197.6% | ||
| Avg | 71.9% | ||
| Low | -9.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.15 | ||
| Avg | -7.94 | ||
| Low | -13.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |